Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study

Pustular and erythrodermic psoriasis are rare and difficult-to-treat conditions. It has recently been shown that interleukin (IL)-17 inhibitors can be very effective among patients with these forms of psoriasis; however, the potential of IL-23 inhibitors is largely unknown. The aim of this multicent...

Descripción completa

Detalles Bibliográficos
Autores principales: Avallone, Gianluca, Maronese, Carlo Alberto, Murgia, Giulia, Carrera, Carlo Giovanni, Mastorino, Luca, Roccuzzo, Gabriele, Dapavo, Paolo, Alberti-Violetti, Silvia, Quaglino, Pietro, Ribero, Simone, Marzano, Angelo Valerio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962195/
https://www.ncbi.nlm.nih.gov/pubmed/36836196
http://dx.doi.org/10.3390/jcm12041662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962195/
https://www.ncbi.nlm.nih.gov/pubmed/36836196
http://dx.doi.org/10.3390/jcm12041662

Ejemplares similares